Peptide Verified
Research Grade Compounds

Age Verification Required

This website contains information about research peptides and laboratory compounds intended for scientific research purposes only.

You must be at least 21 years of age to enter this site.

All products sold by Peptide Verified are for laboratory and research use only. They are not intended for human consumption, veterinary use, or any application outside of controlled research settings. By entering this site you confirm you understand and agree to these terms.

By clicking "Yes" you confirm you are of legal age and agree to our Terms of Use and Research Use disclaimer.

LIMITED OFFERFree shipping on orders over $150 + 10% off your first order with code RESEARCH10
Offer ends in
47hr
:
59min
:
00sec
Research Cart
Independent COA included with every order

Your cart is empty

Add research peptides to get started

Research Catalog/Tirzepatide
≥99% Purity
Tirzepatide
CAS 2023788-19-2
Independent COA
Third-party lab
HPLC Verified
Mass Spec confirmed
GMP Compliant
Batch traceable
MetabolicNew
COA Available

Tirzepatide

Dual GLP-1 and GIP receptor agonist. Sequence and purity verified.

Purity
≥99%
Studies
80+
CAS Number
2023788-19-2
Select Size
Market avg $135.00Save 19%
$109.99
You save
$25.01
SKU: TIRZ-10MG-1 — Market average based on 8 verified competitors

Research use only. COA included with every order.

Free Shipping
Orders over $150
Ships in 1-2 Days
Domestic US
First Order 10% Off
Code: RESEARCH10

About Tirzepatide

Tirzepatide is a synthetic peptide that acts as a dual agonist at both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors. It represents a newer class of incretin-based research compounds and has been the subject of significant published research examining its effects on metabolic pathways, body composition, and glucose homeostasis. Supplied as lyophilized powder at ≥99% purity.

Research Applications

Dual GIP and GLP-1 receptor agonism research
Metabolic regulation and insulin sensitivity
Body composition and adipose tissue models
Incretin pathway pharmacology research